Comprehensive methylome map of lineage commitment from haematopoietic progenitors. 2010

Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
Center for Epigenetics and Department of Medicine, Johns Hopkins University School of Medicine, 570 Rangos, 725 N. Wolfe St., Baltimore, Maryland 21205, USA.

Epigenetic modifications must underlie lineage-specific differentiation as terminally differentiated cells express tissue-specific genes, but their DNA sequence is unchanged. Haematopoiesis provides a well-defined model to study epigenetic modifications during cell-fate decisions, as multipotent progenitors (MPPs) differentiate into progressively restricted myeloid or lymphoid progenitors. Although DNA methylation is critical for myeloid versus lymphoid differentiation, as demonstrated by the myeloerythroid bias in Dnmt1 hypomorphs, a comprehensive DNA methylation map of haematopoietic progenitors, or of any multipotent/oligopotent lineage, does not exist. Here we examined 4.6 million CpG sites throughout the genome for MPPs, common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), granulocyte/macrophage progenitors (GMPs), and thymocyte progenitors (DN1, DN2, DN3). Marked epigenetic plasticity accompanied both lymphoid and myeloid restriction. Myeloid commitment involved less global DNA methylation than lymphoid commitment, supported functionally by myeloid skewing of progenitors following treatment with a DNA methyltransferase inhibitor. Differential DNA methylation correlated with gene expression more strongly at CpG island shores than CpG islands. Many examples of genes and pathways not previously known to be involved in choice between lymphoid/myeloid differentiation have been identified, such as Arl4c and Jdp2. Several transcription factors, including Meis1, were methylated and silenced during differentiation, indicating a role in maintaining an undifferentiated state. Additionally, epigenetic modification of modifiers of the epigenome seems to be important in haematopoietic differentiation. Our results directly demonstrate that modulation of DNA methylation occurs during lineage-specific differentiation and defines a comprehensive map of the methylation and transcriptional changes that accompany myeloid versus lymphoid fate decisions.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016678 Genome The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA. Genomes
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055432 Metabolomics The systematic identification and quantitation of all the metabolic products of a cell, tissue, organ, or organism under varying conditions. The METABOLOME of a cell or organism is a dynamic collection of metabolites which represent its net response to current conditions. Metabonomics,Metabolomic,Metabonomic
D055442 Metabolome The dynamic collection of metabolites which represent a cell's or organism's net metabolic response to current conditions. Metabolic Profile,Metabolic Profiles,Metabolomes,Profile, Metabolic,Profiles, Metabolic

Related Publications

Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
April 1996, The EMBO journal,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
April 2013, Nature,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
December 2015, Cell,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
January 2016, Cell,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
April 2010, Current opinion in immunology,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
September 2014, Science (New York, N.Y.),
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
November 2016, The EMBO journal,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
November 2010, Immunological reviews,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
April 2017, Nature cell biology,
Hong Ji, and Lauren I R Ehrlich, and Jun Seita, and Peter Murakami, and Akiko Doi, and Paul Lindau, and Hwajin Lee, and Martin J Aryee, and Rafael A Irizarry, and Kitai Kim, and Derrick J Rossi, and Matthew A Inlay, and Thomas Serwold, and Holger Karsunky, and Lena Ho, and George Q Daley, and Irving L Weissman, and Andrew P Feinberg
August 2020, Experimental hematology,
Copied contents to your clipboard!